Serum amyloid a, a potential biomarker both in serum and tissue, correlates with ovarian cancer progression

• Main Authors: Ze Li (Author), Yongwang Hou (Author), Meng Zhao (Author), Tianning Li (Author), Yahui Liu (Author), Jiao Chang (Author), Li Ren (Author)
• Format: Book
• Published: BMC, 2020-06-01T00:00:00Z.
• Subjects: article
• Online Access: Connect to this object online.

Abstract Background Ovarian cancer is the most fatal gynecologic malignancy worldwide due to its vagueness, delay in diagnosis, recurrence, and drug resistance. Therefore, a new type of ovarian cancer treatment prediction biomarker is urgently needed to supplement existing tools. A total of 230 peop...